AYUSH MEDICINES: Magic or Logic (2024)
Magic is the use of supernatural forces to create effects that defy natural laws and evoke a sense of wonder.
Magic is an effective use of laws of physics to create illusion and virtual reality to make people believe things that they can't imagine under normal circumstances with common sense.
Many a times due to scientific shortcuts and lack of wisdom or vested intentions, traditional practices are termed Magics.
AYUSH medicines, which include Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy, are sometimes colloquially referred to as "magic remedies" because of their holistic approach to health, centuries-old practices, and the perceived "miraculous" benefits they offer in managing various ailments by the abusers and consortium of evidence based practitioners. This label is often rooted due to popular perception rather than clinical evidence, reflecting how traditional healing systems are seen to work gently and naturally, sometimes achieving results where conventional treatments may fall short. And surprise at most times evoke doubts.
Hence, the term "magic remedies" can be misleading, as AYUSH therapies are grounded in specific philosophical and medicinal principles, and not in supernatural effects. The label sometimes diminishes the scientific foundations and the extensive yet unfortunately undocumented traditional knowledge that backs these systems. The Indian government, through the Ministry of AYUSH, has been promoting scientific research and clinical validation to establish the efficacy of AYUSH therapies more formally.
The term "magic remedies" has not been historically attributed to Ayurvedic medicines by any specific person. However, the phrase gained legal significance in India through the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, which regulates advertisements claiming miraculous cures in Allopathic, Ayurvedic, and other traditional medicines to prevent misleading claims. The act used "magic remedies" broadly to address exaggerated claims rather than any official or scientific designation of Ayurvedic or traditional medicines as magical.
Few examples of companies that faced action for violating the Drugs and Magic Remedies (Objectionable Advertisements) Act in India:
(2016): Company XX was scrutinized for promoting certain products with exaggerated health claims, including remedies for diabetes, blood pressure, and joint pain. The Advertising Standards Council of India (ASCI) flagged multiple ads for making unsubstantiated claims, leading to corrective actions.
YY Ayurveda (2021): YY faced legal issues when its advertisements claimed their products could effectively "cure" serious conditions like diabetes and hypertension. The claims were deemed misleading as they lacked scientific validation.
ZZZZ: Known for producing traditional Ayurvedic products, ZZZZ received warnings for advertisements that overstated the effects of some formulations, including claims to cure serious illnesses, violating the Magic Remedies Act.
These cases emphasize the importance of responsible advertising and adherence to regulations in the AYUSH sector.
Let's understand what specific issues that require tightening of administration.
(2020): AAAA promoted Proxozeen as a COVID-19 "cure" without sufficient scientific evidence. The claim received widespread criticism, leading to government intervention. Authorities required AAAA to revise its labeling and advertise Proxozeen as an immunity booster instead of a cure for COVID-19.
YY Ayurveda Diabetes Cure Claim: YY Ayurveda advertised certain products as a permanent cure for diabetes, without clinical support for the claim. This led the ASCI to issue a warning, highlighting that such ads could mislead patients into abandoning conventional treatment for diabetes management.
ZZZZ's Anti-Asthma and Cancer Treatment Claims: ZZZZ faced scrutiny for ads claiming that certain products could treat asthma and even cancer effectively. These advertisements lacked clinical evidence and were flagged for making unverified promises about serious health conditions.
These examples underscore the importance of evidence-based products and communication with adherence to introductory regulatory standards in licensing AYUSH products responsibly.
To avoid being tagged as "magic remedies," companies manufacturing AYUSH products should:
Follow Scientific Validation: Invest in clinical trials and scientific research to validate claims with evidence-based outcomes at product introduction.
Comply with Regulations: Adhere to guidelines set by regulatory authorities like the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and the Ministry of AYUSH, avoiding exaggerated or misleading health claims.
Use Transparent Marketing: Focus on educational marketing that clearly explains the benefits based on evidence based traditional knowledge and scientific support rather than promising "miraculous" cures.
Label Responsibly: Ensure product labels and advertisements are accurate, emphasizing well-supported benefits and safe usage without overstated promises.
Engage in Certification: Obtain quality certifications (like WHO standard GMP or ISO) to build credibility and consumer trust, emphasizing safety and efficacy.
By maintaining these standards, both AYUSH and its companies can promote products responsibly and enhance public trust in traditional medicine.
There's no shortcuts to success. Ayurvedic companies should not be excused for proper documentation and compliance at product introduction in local markets under Ministry of AYUSH. The companies continue to struggle with the followings even in 2024:
Traditional Knowledge vs. Modern Documentation: Many Ayurvedic formulations are based on traditional recipes without modern validation processes, which may not align with the rigorous documentation standards required for modern healthcare. This results in gaps when substantiating claims with scientific evidence, as traditional practices focus more on holistic benefits than specific, measurable outcomes.
Cost and Complexity of Research: Conducting clinical trials, maintaining strict quality control, and complying with documentation standards require significant investment. Many smaller companies lack the resources to conduct such trials, leading them to bypass extensive documentation to reduce costs. Govt. should come up with a policy to support if the innovation is unique as per committee validation.
Limited Regulatory Oversight: Although the Ministry of AYUSH has set regulatory guidelines (scope for improvement remains and that's an ongoing process), the enforcement of these standards is inconsistent across states. Inspections and audits are often irregular, and smaller companies can sometimes operate without comprehensive scrutiny. This lack of strict oversight allows some companies to launch products with minimal compliance (this needs a strict stoppage).
Lack of Penalties and Follow-Through: The penalties for non-compliance are often not substantial enough to deter companies from cutting corners. The Ministry of AYUSH and local regulators sometimes lack the resources or coordination to impose effective penalties, especially in cases of misleading advertisements or low-quality production practices.
To strengthen the system, the Ministry of AYUSH will come up with stricter compliance checks and enforcements, increase penalties for violations, and improve collaboration with state-level authorities for more consistent oversight. Additionally, providing grand subsidies or incentives for scientific research on AYUSH formulations could encourage companies to invest in proper documentation and clinical validation.
Global Red Flags is a regular phenomenon by multiple countries across developed world makes manufacturers decategorize products to expand global presence and that's mostly because the complex regulation of traditional medicines across different countries. That is largely due to multiple factors, with no single party solely to blame.
Historical and Cultural Variability: Each country has its own historical and cultural ties to traditional medicine, such as Ayurveda in India, Traditional Chinese Medicine in China, and Native American herbal practices in the U.S. These unique roots have led countries to develop independent regulatory standards based on local needs and beliefs rather than a unified global standard.
Lack of Global Regulatory Authority: The World Health Organization (WHO) provides guidance but lacks the power to enforce regulations globally. As a result, countries are free to adapt WHO recommendations to suit their own regulatory frameworks and health policies, leading to varied levels of regulation.
Scientific and Evidence Gaps: The limited availability of scientific research and clinical validation for many traditional medicines makes it difficult to develop global standards. Since evidence-based criteria differ across countries, regulators often rely on local practices and existing cultural acceptance when setting standards, which contributes to inconsistency.
Political and Economic Interests: National interests often shape health regulations. Countries with strong traditional medicine markets may have looser regulatory frameworks to encourage domestic industry growth, while others impose stricter standards to protect their markets or healthcare systems. This variation reflects different political and economic agendas regarding traditional medicine.
Lack of Collaborative Mechanisms: Despite some efforts to promote international collaboration on traditional medicine, limited cross-border regulatory cooperation makes it challenging to achieve harmonized standards. Diverse legal and health priorities make consensus difficult, especially without formal frameworks for international regulatory alignment.
The varied regulation of traditional medicine is a result of historical, cultural, scientific, political, and organizational factors. Greater collaboration between countries, increased funding for scientific research, and a stronger role for organizations like WHO could help address these inconsistencies.
The World Health Organization (WHO) has made strides in acknowledging and integrating traditional medicine through initiatives like its Traditional Medicine Strategy (2014-2023) and the establishment of the Global Centre for Traditional Medicine in Jamnagar, Gujarat, India. However, WHO still faces challenges in effectively evaluating and standardizing traditional medicine globally:
Lack of Standardized Frameworks: Traditional medicine systems vary widely across cultures, with unique methodologies, terminologies, and diagnostic approaches. WHO lacks a unified framework to evaluate the safety, efficacy, and quality of these diverse practices, making it challenging to apply consistent global standards.
Limited Clinical Research and Evidence: Many traditional practices lack large-scale clinical trials or high-quality scientific evidence due to resource constraints or reliance on oral traditions. WHO's focus on evidence-based approaches makes it difficult to assess practices with minimal or culturally distinct documentation.
Funding and Resources: The WHO’s resources are often prioritized for urgent global health issues, leaving limited funding for establishing an independent, robust wing dedicated solely to traditional medicine. This financial limitation affects the organization’s ability to research, standardize, and provide guidance on traditional medicines globally.
Regulatory Diversity and Legal Constraints: Different countries have varied regulatory requirements for traditional medicine. This diversity, combined with WHO's non-regulatory role, limits its ability to enforce guidelines, as WHO can only provide recommendations that countries may or may not adopt.
Balancing Cultural Sensitivity with Scientific Rigor: WHO must respect cultural practices while promoting scientifically validated health practices. Striking this balance is complex and can slow down efforts to create a dedicated wing with rigorous evaluation standards.
To address these gaps, WHO could benefit from increased funding, partnerships with research institutions, and collaboration with regulatory bodies worldwide. This would enhance its capacity to create a comprehensive framework for evaluating traditional medicine systems and foster global acceptance through evidence-based validation.
The Magic Remedy needs to be taken care of with Evidence based Documented approach at origin to ensure all innovations in the field of healthcare doesn't face Tragic Localised Fate.
